Reported Feb 19, 2020 · Terminated
Memantine Hydrochloride Extended Release Capsules, 21 mg, 30-count bottles, Rx Only, Manufactured for: Lupin…
Lupin Pharmaceuticals Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Lupin Pharmaceuticals Inc. · Harborplace Tower · Baltimore, MD · 21202-6174
Is this the product you have?
- Memantine Hydrochloride Extended Release Capsules, 21 mg, 30-count bottles, Rx Only
- Manufactured forLupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 United States
- Manufactured by
Lupin Limited Pithampur (M.P.)-454 775INDIANDC 68180-248-06
- Lot codes and dates
Lot #: H900330exp. date 11/2020
- Amount recalled
- 6,294 bottles
Where it was sold
- Nationwide
Why it was recalled
Failed Dissolution Specifications: Low out of specification results observed in dissolution test at six-month long-term stability study.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Lupin Pharmaceuticals Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.